NICE Technology Appraisal Guidance 58 - use of zanamivir, oseltamivir and amantadine for the treatment of influenza

This guidance has been updated and replaced by TA168 Zanamivir, amantadine and oseltamivir for the treatment of influenza

This advice has been reviewed under our procedure for processing NICE appraisals to ensure it is relevant for the Scottish healthcare landscape.